IGC Pharma, Inc. (IGC) - Latest Market Data

Price & Market Data

Price: $0.288

Daily Change: -$0.0₃9 / 0.31%

Daily Range: $0.28 - $0.42

Market Cap: $28,826,298

Daily Volume: 4,051,982

Performance Metrics

1 Week: 0.07%

1 Month: -6.15%

3 Months: 17.25%

6 Months: -6.15%

1 Year: -8.91%

YTD: 3.52%

About IGC Pharma, Inc. (IGC)

Discover the investment profile of IGC Pharma, Inc. (IGC). With a price of 0.288, and a daily change of -$0.0₃9 / 0.31%. Market cap: 28,826,298. Performance figures include YTD and 52-week returns.

Company Details

Employees: 70

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

Selected stocks

Empire Petroleum Corporation (EP)

AN2 Therapeutics, Inc. (ANTX)

Vivani Medical, Inc. (VANI)

Delixy Holdings Limited (DLXY)